THE APEX TIMES
A new Yahoo Finance-linked analysis weighs Chevron and Mondelez International on dividend yield, framing both as candidates for investors seeking long-term income.
A Yahoo Finance-linked post from Tikr pitched a simple premise for dividend investors: if you could choose only one stock to hold for the next 20 years, which would it be, Chevron or Mondelez International? The comparison centers on dividend yield as the starting point for thinking about long-run cash returns, rather than on short-term price moves.
According to the article, Chevron’s dividend yield is about 3.4%, while Mondelez International’s yield is about 3.0%. The piece presents those starting yields as a key differentiator when investors consider how much income a stock could generate over multiple business cycles.
From there, the post appears to use the concept of “dividend durability” to justify why a higher starting yield might matter, while still acknowledging the broader challenge of maintaining dividend payments through changing economic conditions. But beyond the yield figures cited in the publication summary, the post does not provide verifiable, numbers-heavy detail in the materials available here.
The Chevron side of the comparison aligns with how investors typically view oil and gas majors: dividends that are influenced by commodity prices, upstream and downstream margins, and capital discipline. The Mondelez side fits the consumer staples framing: a business model that many investors associate with steadier demand and a dividend policy designed to support long-term shareholder returns.
Still, the central limitation is disclosure. The Tikr post summary available in this packet does not include the full set of assumptions, valuation inputs, dividend growth forecasts, payout-rate discussion, or scenario analysis that would be needed to evaluate the “20 years” claim rigorously.
In that sense, the article reads more like a framework for making a selection based on yield than a full investment thesis with transparent modeling. Readers would need the full write-up to see what duration, reinvestment assumption, and dividend-growth path the author used to reach a single-choice conclusion.
For investors, the practical takeaway is that dividend yield, while important, is only one layer of a longer-term income strategy. Two stocks can begin with similar yields but diverge materially depending on how management responds to downturns, how earnings evolve, and whether dividends are supported by cash flow.
What to watch next, if you follow the author’s reasoning, is whether the full post details its dividend outlook, including how it treats dividend increases, any risks to payout levels, and how it weighs sector-specific drivers. Without those specifics, the conclusion should be treated as an opinion about process rather than a quantified forecast.
A market-focused note argues the company’s cash-return profile could matter as Wall Street debates whether 2027 can resemble 2022. The company, however, did not provide new disclosure in the cited post.
A market report said the U.S. Securities and Exchange Commission has opened an investigation involving Nvidia as the chipmaker absorbs fallout from a sharp selloff. Investors now have to parse what the agency is looking at and how much the matter could weigh on disclosures and governance.
A reported Phase 3 win for Moderna’s personalized melanoma therapy, used alongside Merck’s Keytruda, is prompting fresh optimism that the mRNA platform can expand beyond infectious disease. Still, key details such as magnitude of benefit and full trial disclosure remain to be validated.
Marques Brownlee said he has placed an order for Tesla’s Cybercab following a 2024 challenge, and Tesla CEO Elon Musk replied “fair enough,” saying he would accept delivery.
A new market read on Booz Allen Hamilton Holding points to a sizable gap between the company’s valuation and the cash flow the business can generate, sharpening questions for investors about how durable profits and cash generation are in the defense IT services market.
The company is pursuing Australian National Immunisation Program listings for its mRNA influenza vaccines after securing a March 2027 agenda spot with the PBAC, a key committee that advises public reimbursement.
A newly announced partnership between Microsoft and Danaher aims to pair AI-assisted capabilities with cloud-based scientific instruments and lab software, including early tools that are already moving toward commercial use.
A new market round-up from Yahoo Finance highlights how lingering discussion among Fed officials about whether interest rates need to rise again can reshape expectations for large, consumer-facing companies like PepsiCo.
The initiative, launched within Aetna, is designed to link a large share of expectant members and their newborns to coordinated maternal and infant care. CVS Health has not, in the reporting, disclosed staffing, clinical protocols, or outcome targets tied to the program.
A fresh round of holiday changes at Target centers on shopping hours and promotions, a shift the company is indicating as part of how it intends to drive demand into the end of the year.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...